Journal Information
Vol. 15. Issue 1.
Pages 52-59 (January - February 2011)
Share
Share
Download PDF
More article options
Vol. 15. Issue 1.
Pages 52-59 (January - February 2011)
Brief communication
Open Access
Neurobrucellosis: clinical, diagnostic, therapeutic features and outcome. Unusual clinical presentations in an endemic region
Visits
4305
Nurgul Ceran1,
Corresponding author
nurgulceran@hotmail.com

Correspondence to: Harem Iskele Caddesi, 80/12 Uskudar, 34668 Istanbul, Turkey Phone: +90 216 3917120.
, Recai Turkoglu2, Ilknur Erdem1, Asuman Inan1, Derya Engin1, Hulya Tireli2, Pasa Goktas1
1 Department of Infectious Diseases Haydarpasa Numune Training and Research Hospital, Istanbul, Turkey
2 Neurology, Haydarpasa Numune Training and Research Hospital, Istanbul, Turkey
This item has received

Under a Creative Commons license
Article information
Abstract
Bibliography
Download PDF
Statistics
Abstract

Brucellosis is a zoonotic infection and has endemic characteristics. Neurobrucellosis is an uncommon complication of this infection. The aim of this study was to present unusual clinical manifestations and to discuss the management and outcome of a series of 18 neurobrucellosis cases. Initial clinical manifestations consist of pseudotumor cerebri in one case, white matter lesions and demyelinating syndrome in three cases, intracranial granuloma in one case, transverse myelitis in two cases, sagittal sinus thrombosis in one case, spinal arachnoiditis in one case, intracranial vasculitis in one case, in addition to meningitis in all cases. Eleven patients were male and seven were female. The most prevalent symptoms were headache (83%) and fever (44%). All patients were treated with rifampicin, doxycycline plus trimethoprim-sulfamethoxazole or ceftriaxone. Duration of treatment (varied 3-12 months) was determined on basis of the CSF response. In four patients presented with left mild sequelae including aphasia, hearing loss, hemiparesis. In conclusion, although mortality is rare in neurobrucellosis, its sequelae are significant. In neurobrucellosis various clinical and neuroradiologic signs and symptoms can be confused with other neurologic diseases. In inhabitants or visitors of endemic areas, neurobrucellosis should be kept in mind in cases that have unusual neurological manifestations.

Keywords:
neurobrucellosis
serology
diagnosis
neuroimaging
Full text is only aviable in PDF
References
[2.]
J.E. Young.
Brucella species.
Principles and Practice of Infectious Diseases, pp. 2669-2674
[3.]
G. Pappas, N. Akritidis, M. Bosilkovski, E. Tsianos.
N Engl J Med, 352 (2005), pp. 2325-2336
[4.]
J.D. Colmenero, L.M. Reguera, F. Martos, D. Sanchez-De-Mora, M. Delgado, et al.
Complication associated with Brucella melitensis infection: a study of 530 cases.
Medecine, 75 (1996), pp. 195-211
[5.]
A.R. Shakir, A.S.N. Al-Dın, F. Araj, A.R. Lulu, A.R. Mousa, et al.
Clinical categories of neurobrucellosis.
Brain, 110 (1987), pp. 213-223
[6.]
J. Pascal, O. Combarros, J.M. Polo, J. Berciano.
Localized CNS brucellosis: report of 7 cases.
Acta Neurol Scand, 78 (1988), pp. 282-289
[7.]
M.M. Lubani, K.I. Dudin, G.F. Araj, D.S. Manandhar.
Neurobrucellosis in children.
Pediatr Infect Dis J, 8 (1989), pp. 79-82
[8.]
R. Bashir, M.Z. Faan, E.J.H. Faan, J. Jinkins.
Nervous system brucellosis: diagnosis and treatment.
Neurology, 35 (1985), pp. 1576-1581
[9.]
G. Seidel, C.A. Pardo, David Newman-Toker, A. Olivi, C.G. Eberhart.
Neurobrucellosis presenting as leukoencephalopathy.
Arch Pathol Lab Med, 127 (2003), pp. e374-e377
[10.]
I.A. Al-Orainey, M.A. Laajam, A.K. Al-Aska, C.N. Rajapakse.
Brucella meningitis.
J Infect, 14 (1987), pp. 141-145
[11.]
D.R. McLean, N. Russell, M.Y. Khan.
Neurobrucellosis: clinical and therapeutic features.
Clin Infect Dis, 15 (1992), pp. 582-590
[12.]
H. Akdeniz, H. Irmak, Ö. Anlar, A.P. Demiröz.
Central nervous system brucellosis: presentation, diagnosis and treatment.
J Infect, 36 (1998), pp. 297-301
[13.]
M. Namıduru, I. Karaoglan, M. Yılmaz.
Guillain-Barre syndrome associated with acute neurobrucellosis.
Int J Clin Pract, 10 (2003), pp. 919-920
[14.]
F. Çokça, A. Azap, O. Meço.
Bilateral mammary abscess due to Brucella melitensis.
Scand J Infect Dis, 31 (1999), pp. 318-319
[15.]
G.K. Dakdouki, G.F. Araj, G.N. Awar.
Buttock abscess brucellosis.
Scand J Infect Dis, 34 (2002), pp. 934-936
[16.]
G.V. Vajramani, M.B. Nagmoti, C.S. Patil.
Neurobrucellosis presenting as an intra-medullary spinal cord abscess.
Ann Clin Microb Antimicrob, 16 (2005), pp. 14
[17.]
A. Bucher, P. Gaustad, E. Pape.
Chronic neurobrucellosis due to Brucella melitensis.
Scand J Infect Dis, 22 (1990), pp. 223-226
[18.]
H. Güvenç, K. Kocabay, A. Ökten, S. Bektas.
Brucellosis in a child complicated with multiple brain abscesses.
Scand J Infect Dis, 21 (1989), pp. 333-336
[19.]
G.F. Araj, A.R. Lulu, M.A. Saadah, A.M. Mousa, L. Strannegard, et al.
Rapid diagnosis of central nervous system brucellosis by ELISA.
J Neuroimmunol, 12 (1986), pp. 173-182
[20.]
P.C. Baldi, G.F. Araj, G.C. Racaro, J.C. Wallach, C.A. Fossati.
Detection of antibodies to brucella cyoplasmic proteins in the cerebrospinal fluid of patients with neurobrucellosis.
Clin Diag Lab Immunol, 6 (1999), pp. 756
[21.]
A. Sanchez-Sousa, C. Torres, M.G. Campello, C. Garcia, F. Parras, et al.
Serological diagnosis of neurobrucellosis.
J Clin Pathol, (1990), pp. 79-81
[22.]
M.W. Al-Sous, S. Bohlega, Al-Kawi, J. Alwatban, R. McLean.
Neurobrucellosis: clinical and neuroimaging correlation.
Am J Neuro Radiol, 25 (2004), pp. 395
[23.]
E. Martinez-Chamorro, A. Munoz, J. Esparza, M.J. Munoz, E. Giangaspro.
Focal cerebral involvement by neurobrucellosis: pathological and MRI findings.
Eur J Radiol, 43 (2002), pp. 28-30
[24.]
I. Adaletli, S. Albayram, B. Gurses, H. Ozer, M.H. Yılmaz, et al.
Vasculopathic changes in the cerebral arterial system with neurobrucellosis.
Am J Neuro Radiol, 27 (2006), pp. 384-386
[25.]
G.K. Daikos, N. Papapolyzos, N. Marketos, S. Mochlas, S. Kastanakis, et al.
Trimetoprim-Sulfamethoxazole in brucellosis.
J Infect Dis, 128 (1973), pp. 731-733
[26.]
M. Doganay, B. Aygen.
Use of ciprofloxacin in the treatment of brucellosis.
Eur J Clin Microbiol Infect Dis, 11 (1992), pp. 74-75
[27.]
C. Agalar, S. Usubütün, R. Türkyılmaz.
Ciprofloxacin and rifampicin versus doxcyclinee and rifampicin in the treatment of brucellosis.
Eur J Clin Microbiol Infect Dis, 18 (1999), pp. 535-538
[28.]
G.A. Gogos, T.G. Maraziotis, N. Papadakis, D. Beerman, D.K. Siamplis, et al.
Penetration of ciprofloxacin into human cerbrospinal fluid in patients with inflamed and noninflamed meninges.
Eur J Clin Microbiol Infect Dis, 10 (1991), pp. 511-514
[29.]
H.Y. Al-Idrissi, A.K. Uwaydah, K.T. Danso, H. Qutub, M.S. Al-Mousa.
Ceftriaxone in the treatment of acute and subacute human brucellosis.
J Int Med Research, 17 (1989), pp. 363-368
[30.]
T. Pellicer, J. Ariza, A. Foz, R. Pallarez, F. Gudiol.
Specific antibodies detected during relapse of human brucellosis.
J Infect Dis, 157 (1988), pp. 918-924
Copyright © 2011. Elsevier Editora Ltda.. All rights reserved
Download PDF
The Brazilian Journal of Infectious Diseases
Article options
Tools